强生公司 (NYSE: JNJ )宣布，美国食品药品监督管理局 (FDA) 已授予 posdinemab 快速通道资格，posdinemab 是一种针对磷酸化 tau 的单克隆抗体 ...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...

Johnson & Johnson?s mobile ads for its Head-to-Toe baby lotion within the What to Expect iPhone application are seeing a 3 percent click-through-rate. What To Expect is a spin-off of the famous ?What ...

Johnson & Johnson is currently gearing up to initiate a phase I study on KP-723 to treat AD in 2025. The company also expects to investigate the candidate in other Th2-mediated diseases, including ...

Johnson & Johnson (JNJ) closed the latest trading day at $166.09, indicating a +1.44% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.47%. Elsewhere ...

Johnson & Johnson (JNJ) closed the latest trading day at $157.89, indicating a +1.87% change from the previous session's end. This move outpaced the S&P 500's daily gain of 0.24%. At the same time ...

We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires. In this article, we are going to ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend stocks. During a time of great excitement about AI-driven capital gains ...